Published in Immunol Res on January 01, 2007
Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile. J Exp Med (2010) 1.68
Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1. Invest Ophthalmol Vis Sci (2008) 1.10
TNF receptor-associated factor 5 is required for optimal T cell expansion and survival in response to infection. J Immunol (2008) 1.03
The germinal center kinase TNIK is required for canonical NF-κB and JNK signaling in B-cells by the EBV oncoprotein LMP1 and the CD40 receptor. PLoS Biol (2012) 0.94
Aberrant CD40-induced NF-κB activation in human lupus B lymphocytes. PLoS One (2012) 0.86
Strategies for the identification of ubiquitin ligase inhibitors. Biochem Soc Trans (2010) 0.85
Lipid rafts in immune signalling: current progress and future perspective. Immunology (2016) 0.80
Roles of the kinase TAK1 in CD40-mediated effects on vascular oxidative stress and neointima formation after vascular injury. PLoS One (2014) 0.78
CD40/TRAF6 switch in neointimal hyperplasia. Blood (2008) 0.75
In silico investigation of potential TRAF6 inhibitor from traditional Chinese medicine against cancers. Biomed Res Int (2014) 0.75
MST-4 and TRAF-6 expression in the peripheral blood mononuclear cells of patients with Graves' disease and its significance. BMC Endocr Disord (2017) 0.75